Advertisement

Pharmacy

Advertisement

Gretchen Liu, a 78-year-old patient, was prescribed telmisartan two years ago to manage her blood pressure after a transient ischemic attack, also known as a mini stroke. A 90-day supply cost her $285 with insurance, when the drug itself was…

Despite opposition from pharmacy benefit managers, HHS Secretary Alex Azar said his agency has the power to eliminate prescription drug rebates — a key element in the prescription medicine cost debate, Reuters reports.

After five months on the job, Gilead Sciences CMO Andrew Cheng, MD, is leaving — joining the growing number of top executives to depart the biotech company in the last seven months, according to the San Francisco Business Journal.

Advertisement